Navigation Links
Talyst Unveils InSite for Long-Term Care
Date:11/19/2008

BELLEVUE, Wash., Nov. 19 /PRNewswire/ -- Talyst, a leader in automated medication management, today unveiled InSite(TM) for Long-Term Care. InSite is the first remote dispensing system designed exclusively for long-term care facilities and the patients in their care.

The company made the announcement at the annual meeting of the American Society of Consultant Pharmacists, underway this week in New Orleans. The first installations of the InSite system are operating in Texas, and each InSite unit will deliver an estimated 1.5 million oral medication doses per year. The automated system enables on-site, on-demand medication dispensing for an entire facility. With InSite for Long-Term Care, medication waste is virtually eliminated. The hardware and software solution cuts nursing medication prep time in half and allows late admissions and quick first doses.

The benefits of remote dispensing

InSite allows an institutional pharmacy to place a secure, freestanding remote dispensing system at each long-term care facility they support. "Talyst is continuing to build market leadership through innovation," explains Carla Corkern, chief executive officer, "and InSite is our response to a clear need in the long-term care industry." She added, "With a national nursing shortage, rising medication budgets and the need for improved medication safety, InSite for Long-Term Care can help both facilities and pharmacies save time and reduce waste while creating a safer medication process."

The InSite Remote Dispensing System improves the partnership between pharmacies and the facilities they support. Medication orders are submitted to the institutional pharmacy for clinical review, and approved orders are available immediately from the remote dispensing unit at the facility. Rather than filling medication orders for 30 days at a time, InSite enables medications to be sorted by patient and packaged at the fac
'/>"/>

SOURCE Talyst
Copyright©2008 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2 3

Related medicine news :

1. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
2. Catalyst mystery unlocked
3. CATalyst Council Forms to Address Feline Health Care
4. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
5. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
6. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
7. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
8. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
9. CATalyst Summit Declared a Success: Its All About the Cat!
10. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
11. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 1Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 2Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 4Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 5AMT Appoints New Chief Executive Officer 58224 1AMT Appoints New Chief Executive Officer 58224 2AMT Appoints New Chief Executive Officer 58224 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 1ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 2ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 4